Drug Trial Radar · NCT07683793
A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants
Last checked: Nov 19, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Oct 14, 2026
Primary completion
Dec 9, 2026
Study completion Dec 9, 2026
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Jul 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase 1 study evaluates the effect of pantoprazole (a proton pump inhibitor) on the pharmacokinetics (PK) of CHF10196 (Florensocatib) in healthy male participants. Participants receive CHF10196 alone and in combination with pantoprazole to assess potential drug-drug interaction (DDI) effects on systemic exposure.
Conditions
- Healthy Volunteers
Interventions
CHF10196Drug
Treatment Period 1: CHF10196 single dose administration on Day1; Treatment Period 2: CHF10196 single dose administration after pantoprazole single dose administration on Day13
PantoprazoleDrug
Treatment Period 2: Pantoprazole single dose administration from Day8 to Day13
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK parameter: AUC0-∞Time frame: pre-dose up to 168 hours post-dose
- PK parameter: AUC0-tTime frame: pre-dose up to 168 hours post-dose
- PK parameter: CmaxTime frame: pre-dose up to 168 hours post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fortrea Clinical Research Unit (CRU) Limited
Leeds, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.